← NewsEarnings

Is Oklo a Buy at $44? A $3 Billion War Chest, $1.2 Million of Revenue, and a Decade of In-Between

Is Oklo a buy after Q2 earnings? Revenue of $1.21 million beat, the loss of $0.28 missed, cash sits at $3.0 billion and the stock rose to $44. No: the stock is a bet on milestones, not quarters.

By Atul Ghandhi$OKLO

TL;DR

  • No at $44, and quarterly earnings are the wrong lens entirely.
  • The Q2 numbers in one breath: revenue of $1.21 million beat a $0.1 million estimate, the loss of $0.28 per share missed the $0.16 expected, and the stock rose about 5.4% toward $44.46 anyway, from a $42.19 close.
  • The number that actually matters: $3.0 billion of cash and marketable securities, a war chest that buys years of runway.
  • The valuation asks the question the income statement cannot answer: billions of market value against roughly a million dollars of quarterly revenue is a bet on reactors that do not exist yet.

More on $OKLO: Oklo Earnings (August 7): First Revenue of $1.21 Million, and Criticality Came From the Other Reactor

Is Oklo a Buy After Q2?

No, with respect for what the company is building. Oklo is not mispriced the way a normal stock is mispriced; it is a venture-stage nuclear developer that happens to trade publicly, and at $44 the market has pre-paid for a deployment schedule that regulatory reality has not signed yet. When revenue is $1.21 million and the beat was $1.1 million of it, the quarter is not information. The stock rising on an EPS miss confirms it: nobody owns OKLO for the quarters.

What they own it for is the sequence: licensing progress, a first deployed reactor, and the AI data-centre power demand that has made every credible electron source a strategic asset. That demand is real and the $3 billion war chest means Oklo can afford the long road, which removes the classic pre-revenue killer, dilution at gunpoint. Those are genuine strengths, and they are also fully rehearsed in a stock that has already priced years of flawless execution.

The Milestone Ledger

The way I would actually track this, since quarters will not help:

  • Regulatory approvals. Each licensing step is worth more than any earnings report this decade. The bet's clock runs on regulators, not fiscal calendars.
  • First steel, first electrons. A construction start with a dated completion, then a reactor delivering power to a paying customer. Everything before that is optionality.
  • Contracted customers. Data-centre power agreements with named counterparties and dollar values would convert story to backlog, the way the AI power trade has rewarded elsewhere.
  • The cash burn against the $3 billion. The one income-statement line that matters: runway is the moat while revenue is a rounding error.

An entry interests me on either of two conditions: a milestone the market undersells, or a drawdown that stops charging admission for the whole roadmap. Neither is present at $44 after an up-move on a loss.

The One-Line Read

Oklo at $44 is a well-funded, decade-long bet being graded by a market that just bid it up on a $1.2 million revenue quarter: the call is no, not because the reactors will not come, but because the price already assumes they will, on time, and nuclear timelines have never once worked that way.

Share

More on $OKLO

All $OKLO coverage in one place →

Updated Every Saturday

The Week Ahead

Every earnings date, Fed event and setup for the current trading week, on one page.

Refreshed Weekly

Earnings Calendar

Who reports next, when, and what consensus and the whisper expect.

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Saturday brief.

Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.

Comments

0 total
0/1000
Sign up or sign in to comment

No comments yet. Be the first to drop a take.